Accessing chemical diversity from the uncultivated symbionts of small marine animals

Nature Chemical Biology

Volumn 14, Issue 2, 2018, Pages 179-185

  Smith, Thomas E ^a   Pond, Christopher D ^a   Pierce, Elizabeth ^a   Harmer, Zachary P ^a   Kwan, Jason ^a   Zachariah, Malcolm M ^a   Harper, Mary Kay ^a   Wyche, Thomas P ^b   Matainaho, Teatulohi K ^c   Bugni, Tim S ^b   Barrows, Louis R ^a   Ireland, Chris M ^a   Schmidt, Eric W ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIVAMIDE DERIVATIVE; NATURAL PRODUCT; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; DNA; LYSINOALANINE; PEPTIDE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL PROTECTION; CHEMICAL ANALYSIS; DRUG SYNTHESIS; MARINE SPECIES; METAGENOME; NONHUMAN; PAPUA NEW GUINEA; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; SYMBIONT; SYNTHETIC BIOLOGY; UROCHORDATA; ANIMAL; BACTERIUM; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECT; GENOMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METAGENOMICS; MICROFLORA; MULTIGENE FAMILY; PRECLINICAL STUDY; SYMBIOSIS; T LYMPHOCYTE;

ANIMALS; ANTI-HIV AGENTS; BACTERIA; BIOLOGICAL PRODUCTS; DNA; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GENOMICS; HIV INFECTIONS; HUMANS; LYSINOALANINE; METAGENOME; METAGENOMICS; MICROBIOTA; MULTIGENE FAMILY; PEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; SYMBIOSIS; SYNTHETIC BIOLOGY; T-LYMPHOCYTES; UROCHORDATA;

EID: 85040764392     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.2537     Document Type: Article

References (59)

1. Blunt, J.W., Copp, B.R., Keyzers, R.A., Munro, M.H. &Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 33, 382-431 (2016)
2. Miller, I.J., Vanee, N., Fong, S.S., Lim-Fong, G.E. &Kwan, J.C. Lack of overt genome reduction in the bryostatin-producing bryozoan symbiont "Candidatus Endobugula sertula.". Appl. Environ. Microbiol. 82, 6573-6583 (2016)
3. Schofield, M.M., Jain, S., Porat, D., Dick, G.J. &Sherman, D.H. Identification and analysis of the bacterial endosymbiont specialized for production of the chemotherapeutic natural product ET-743. Environ. Microbiol. 17, 3964-3975 (2015)
4. Schmidt, E.W. et al. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc. Natl. Acad. Sci. USA 102, 7315-7320 (2005)
5. Donia, M.S. et al. A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics. Cell 158, 1402-1414 (2014)
6. Guo, C.J. et al. Discovery of reactive microbiota-derived metabolites that inhibit host proteases. Cell 168, 517-526. e18 (2017)
7. Donia, M.S., Ruffner, D.E., Cao, S. &Schmidt, E.W. Accessing the hidden majority of marine natural products through metagenomics. ChemBioChem 12, 1230-1236 (2011)
8. Lewin, R.A. Prochlorophyta as a proposed new division of algae. Nature 261, 697-698 (1976)
9. Donia, M.S. et al. Complex microbiome underlying secondary and primary metabolism in the tunicate-Prochloron symbiosis. Proc. Natl. Acad. Sci. USA 108, E1423-E1432 (2011)
10. Arnison, P.G. et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat. Prod. Rep. 30, 108-160 (2013)
11. Willey, J.M. &van der Donk, W.A. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61, 477-501 (2007)
12. Widdick, D.A. et al. Cloning and engineering of the cinnamycin biosynthetic gene cluster from Streptomyces cinnamoneus cinnamoneus DSM 40005. Proc. Natl. Acad. Sci. USA 100, 4316-4321 (2003)
13. Fredenhagen, A. et al. Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. J. Antibiot. (Tokyo) 43, 1403-1412 (1990)
14. Knerr, P.J. &van der Donk, W.A. Discovery, biosynthesis, and engineering of lantipeptides. Annu. Rev. Biochem. 81, 479-505 (2012)
15. Huo, L., Okesli, A., Zhao, M. &van der Donk, W.A. Insights into the biosynthesis of duramycin. Appl. Environ. Microbiol. 83, e02698-16 (2017)
16. O'Rourke, S., Widdick, D. &Bibb, M. A novel mechanism of immunity controls the onset of cinnamycin biosynthesis in Streptomyces cinnamoneus DSM 40646. J. Ind. Microbiol. Biotechnol. 44, 563-572 (2017)
17. Okesli, A., Cooper, L.E., Fogle, E.J. &van der Donk, W.A. Nine posttranslational modifications during the biosynthesis of cinnamycin. J. Am. Chem. Soc. 133, 13753-13760 (2011)
18. Cameron, D.M. et al. Thermus thermophilus L11 methyltransferase, PrmA, is dispensable for growth and preferentially modifies free ribosomal protein L11 prior to ribosome assembly. J. Bacteriol. 186, 5819-5825 (2004)
19. Dai, X. et al. Identification of novel A-n-methylation of CENP-B that regulates its binding to the centromeric DNA. J. Proteome Res. 12, 4167-4175 (2013)
20. Dognin, M.J. &Wittmann-Liebold, B. The primary structure of L11, the most heavily methylated protein from Escherichia coli ribosomes. FEBS Lett. 84, 342-346 (1977)
21. Zhang, K. et al. Differentiation between peptides containing acetylated or tri-methylated lysines by mass spectrometry: an application for determining lysine 9 acetylation and methylation of histone H3. Proteomics 4, 1-10 (2004)
22. Donia, M.S., Fricke, W.F., Ravel, J. &Schmidt, E.W. Variation in tropical reef symbiont metagenomes defined by secondary metabolism. PLoS One 6, e17897 (2011)
23. Tianero, M.D. et al. Metabolic model for diversity-generating biosynthesis. Proc. Natl. Acad. Sci. USA 113, 1772-1777 (2016)
24. Pannecouque, C., Daelemans, D. &De Clercq, E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later. Nat. Protoc. 3, 427-434 (2008)
25. Marki, F., Hanni, E., Fredenhagen, A. &van Oostrum, J. Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2. Biochem. Pharmacol. 42, 2027-2035 (1991)
26. Iwamoto, K. et al. Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin. Biophys. J. 93, 1608-1619 (2007)
27. Machaidze, G. &Seelig, J. Specific binding of cinnamycin (Ro 09-0198) to phosphatidylethanolamine. Comparison between micellar and membrane environments. Biochemistry 42, 12570-12576 (2003)
28. Choung, S.Y. et al. Hemolytic activity of a cyclic peptide Ro09-0198 isolated from Streptoverticillium. Biochim. Biophys. Acta 940, 171-179 (1988)
29. Makino, A. et al. Cinnamycin (Ro 09-0198) promotes cell binding and toxicity by inducing transbilayer lipid movement. J. Biol. Chem. 278, 3204-3209 (2003)
30. Richard, A.S. et al. Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proc. Natl. Acad. Sci. USA 112, 14682-14687 (2015)
31. Tabata, T. et al. Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission. Cell Host Microbe 20, 155-166 (2016)
32. Wakamiya, T., Fukase, K., Naruse, N., Konishi, M. &Shiba, T. Lanthiopeptin, a new peptide effective against Herpes simplex virus: structural determination and comparison with Ro 09-0198, an immunopotentiating peptide. Tetrahedr. Lett. 29, 4771-4772 (1988)
33. Yates, K.R. et al. Duramycin exhibits antiproliferative properties and induces apoptosis in tumour cells. Blood Coagul. Fibrinolysis 23, 396-401 (2012)
34. Zhao, M. Lantibiotics as probes for phosphatidylethanolamine. Amino Acids 41, 1071-1079 (2011)
35. Medema, M.H. &Fischbach, M.A. Computational approaches to natural product discovery. Nat. Chem. Biol. 11, 639-648 (2015)
36. Chu, J. et al. Discovery of MRSA active antibiotics using primary sequence from the human microbiome. Nat. Chem. Biol. 12, 1004-1006 (2016)
37. Challis, G.L. &Ravel, J. Coelichelin, a new peptide siderophore encoded by the Streptomyces coelicolor genome: structure prediction from the sequence of its non-ribosomal peptide synthetase. FEMS Microbiol. Lett. 187, 111-114 (2000)
38. Skinnider, M.A. et al. Genomes to natural products PRediction Informatics for Secondary Metabolomes (PRISM). Nucleic Acids Res. 43, 9645-9662 (2015)
39. Blin, K. et al. antiSMASH 4.0-improvements in chemistry prediction and gene cluster boundary identification. Nucleic Acids Res. 45, W36-W41 (2017)
40. Li, M. et al. TIM-family proteins inhibit HIV-1 release. Proc. Natl. Acad. Sci. USA 111, E3699-E3707 (2014)
41. Kondratowicz, A.S. et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl. Acad. Sci. USA 108, 8426-8431 (2011)
42. Meertens, L. et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe 12, 544-557 (2012)
43. Firn, R.D. &Jones, C.G. A Darwinian view of metabolism: molecular properties determine fitness. J. Exp. Bot. 60, 719-726 (2009)
44. Kliebenstein, D.J. A role for gene duplication and natural variation of gene expression in the evolution of metabolism. PLoS One 3, e1838 (2008)
45. Lin, Z., Torres, J.P., Tianero, M.D., Kwan, J.C. &Schmidt, E.W. Origin of chemical diversity in Prochloron-tunicate symbiosis. Appl. Environ. Microbiol. 82, 3450-3460 (2016)
46. Li, B. et al. Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc. Natl. Acad. Sci. USA 107, 10430-10435 (2010)
47. Sardar, D., Pierce, E., McIntosh, J.A. &Schmidt, E.W. Recognition sequences and substrate evolution in cyanobactin biosynthesis. ACS Synth. Biol. 4, 167-176 (2015)
48. Cubillos-Ruiz, A., Berta-Thompson, J.W., Becker, J.W., van der Donk, W.A. &Chisholm, S.W. Evolutionary radiation of lanthipeptides in marine cyanobacteria. Proc. Natl. Acad. Sci. USA 114, E5424-E5433 (2017)
49. Hirose, M., Nozawa, Y. &Hirose, E. Genetic isolation among morphotypes in the photosymbiotic didemnid Didemnum molle (Ascidiacea, Tunicata) from the Ryukyus and Taiwan. Zool. Sci. 27, 959-964 (2010)
50. Burton, I.W., Quilliam, M.A. &Walter, J.A. Quantitative 1H NMR with external standards: use in preparation of calibration solutions for algal toxins and other natural products. Anal. Chem. 77, 3123-3131 (2005)
51. Sokolov, E.P. An improved method for DNA isolation from mucopolysaccharide-rich molluscan tissues. J. Molluscan Stud. 66, 573-575 (2000)
52. Tianero, M.D. et al. Species specificity of symbiosis and secondary metabolism in ascidians. ISME J. 9, 615-628 (2015)
53. Zerbino, D.R. &Birney, E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18, 821-829 (2008)
54. Buhr, F. et al. Synonymous codons direct cotranslational folding toward different protein conformations. Mol. Cell 61, 341-351 (2016)
55. He, Z. et al. Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin. Appl. Environ. Microbiol. 73, 168-178 (2007)
56. Kawulka, K.E. et al. Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to A-carbon cross-links: formation and reduction of A-thio-A-amino acid derivatives. Biochemistry 43, 3385-3395 (2004)
57. Chen, H., Boyle, T.J., Malim, M.H., Cullen, B.R. &Lyerly, H.K. Derivation of a biologically contained replication system for human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89, 7678-7682 (1992)
58. Kiser, R., Makovsky, S., Terpening, S.J., Laing, N. &Clanton, D.J. Assessment of a cytoprotection assay for the discovery and evaluation of anti-human immunodeficiency virus compounds utilizing a genetically-impaired virus. J. Virol. Methods 58, 99-109 (1996)
59. Hou, S., Johnson, S.E. &Zhao, M. A One-step staining probe for phosphatidylethanolamine. ChemBioChem 16, 1955-1960 (2015)